Tumor-reactive CD8(cid:1) TCM are superior to TEM in the treatment of B16
Fig. 5.
melanoma. (A) Sublethally irradiated (5 Gy) WT mice bearing 9-day B16
tumors were left untreated as controls (F) or received rFPhgp100 vaccination,
exogenous IL-2, and either pmel TCM (â– 
) or TEM ((cid:1)). (B) Enhanced tumor
regression in mice receiving pmel TCM correlated with statistically prolonged
animal survival, compared with mice receiving TEM.
